Jin Rong Ow

Jin Rong Ow

Auto-generated profile, based on publicly available information

Jin Rong Ow

Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research)

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Epigenetics
Verified
Journal Article
Open access
PDF file
SSShilpa Rani Shankar
Shilpa Rani Shankar
ABAvinash G. Bahirvani
Avinash G. Bahirvani
VRVinay Kumar Rao
Vinay Kumar Rao
NBNarendra Bharathy
Narendra Bharathy
JOJin Rong Ow
Jin Rong Ow
RTReshma Taneja
Reshma Taneja
Lysine methylation of histone and non-histone substrates by the methyltransferase G9a is mostly associated with transcriptional repression. Recent studies, however, have highlighted its role as an activator of gene expression through mechanisms that are independent of its methyltransferase activity. Here we review the growing repertoire of molecular mechanisms and substrates through which G9a regulates gene expression. We also discuss emerging evidence for its wide-ranging functions in development, pluripotency, cellular differentiation and cell cycle regulation that underscore the complexity of its functions. The deregulated expression of G9a in cancers and other human pathologies suggests that it may be a viable therapeutic target in various diseases.

22 December 2015 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MCMin Hee Choi
Min Hee Choi
JOJin Rong Ow
Jin Rong Ow
NYNai-Di Yang
Nai-Di Yang
RTReshma Taneja
Reshma Taneja
Oxidative stress is a loss of balance between the production of reactive oxygen species during cellular metabolism and the mechanisms that clear these species to maintain cellular redox homeostasis. Increased oxidative stress has been associated with muscular dystrophy, and many studies have proposed mechanisms that bridge these two pathological conditions at the molecular level. In this review, the evidence indicating a causal role of oxidative stress in the pathogenesis of various muscular dystrophies is revisited. In particular, the mediation of cellular redox status in dystrophic muscle by NF‐κB pathway, autophagy, telomere shortening, and epigenetic regulation are discussed. Lastly, the current stance of targeting these pathways using antioxidant therapies in preclinical and clinical trials is examined.

26 May 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VRVinay Kumar Rao
Vinay Kumar Rao
JOJin Rong Ow
Jin Rong Ow
SSShilpa Rani Shankar
Shilpa Rani Shankar
NBNarendra Bharathy
Narendra Bharathy
JMJayapal Manikandan
Jayapal Manikandan
RTReshma Taneja
Reshma Taneja
Differentiation of skeletal muscle cells, like most other cell types, requires a permanent exit from the cell cycle. The epigenetic programming underlying these distinct cellular states is not fully understood. In this study, we provide evidence that the lysine methyltransferase G9a functions as a central axis to regulate proliferation and differentiation of skeletal muscle cells. Transcriptome analysis of G9a knockdown cells revealed deregulation of many cell cycle regulatory genes. We demonstrate that G9a enhances cellular proliferation by two distinct mechanisms. G9a blocks cell cycle exit via methylation-dependent transcriptional repression of the MyoD target genes p21Cip/Waf1 and Rb1. In addition, it activates E2F1-target genes in a methyltransferase activity-independent manner. We show that G9a is present in the E2F1/PCAF complex, and enhances PCAF occupancy and histone acetylation marks at E2F1-target promoters. Interestingly, G9a preferentially associates with E2F1 at the G1/S phase and with MyoD at the G2/M phase. Our results provide evidence that G9a functions both as a co-activator and a co-repressor to enhance cellular proliferation and inhibit myogenic differentiation.

15 May 2014 in Stem Cells and Development
Verified
Journal Article
Closed access
JOJin Rong Ow
Jin Rong Ow
HMHui Ma
Hui Ma
AJAngela Jean
Angela Jean
ZGZiyi Goh
Ziyi Goh
YLYun Hwa Lee
Yun Hwa Lee
QWQiang Wu
Qiang Wu
Embryonic stem cells (ESCs) derived from the inner cell mass (ICM) of blastocysts are pluripotent. Pluripotency is maintained by a transcriptional network in which Oct4 and Nanog are master regulators. Notably, several zinc finger transcription factors have important roles in this network. Patz1, a BTB/POZ-domain-containing zinc finger protein, is expressed at higher levels in the ICM relative to the trophectoderm. However, its function in pluripotency has been poorly studied. Here, we show that Patz1 is an important regulator of pluripotency in ESCs. Patz1 RNAi, chromatin immunoprecipitation (ChIP), and reporter assays indicate that Patz1 directly regulates Pou5f1 and Nanog. Global transcriptome changes upon Patz1 knockdown largely involve upregulation of apoptotic genes and downregulation of cell cycle and cellular metabolism genes. Patz1 ChIP sequencing further identified more than 5,000 binding sites of Patz1 in mouse genome, from which two binding motifs were extracted. Further, gene ontology analysis of genes associated with the binding sites displays enrichment for proximity to developmental genes. In addition, embryoid body assays suggest that Patz1 represses developmental genes. Together, these results propose that Patz1 is important for ESC pluripotency.

4 November 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MDMatthew Dewhurst
Matthew Dewhurst
JOJin Ow
Jin Ow
GZGözde Zafer
Gözde Zafer
NHNoémi Van Hul
Noémi Van Hul
HWHeike Wollmann
Heike Wollmann
PKPhilipp Kaldis
Philipp Kaldis
The liver possesses a remarkable regenerative capacity based partly on the ability of hepatocytes to re-enter the cell cycle and divide to replace damaged cells. This capability is substantially reduced upon chronic damage, but it is not clear if this is a cause or consequence of liver disease. Here, we investigate whether blocking hepatocyte division using two different mouse models affects physiology as well as clinical liver manifestations like fibrosis and inflammation. We find that in P14 Cdk1Liv-/- mice, where the division of hepatocytes is abolished, polyploidy, DNA damage, and increased p53 signaling are prevalent. Cdk1Liv-/- mice display classical markers of liver damage two weeks after birth, including elevated ALT, ALP, and bilirubin levels, despite the lack of exogenous liver injury. Inflammation was further studied using cytokine arrays, unveiling elevated levels of CCL2, TIMP1, CXCL10, and IL1-Rn in Cdk1Liv-/- liver, which resulted in increased numbers of monocytes. Ablation of CDK2-dependent DNA re-replication and polyploidy in Cdk1Liv-/- mice reversed most of these phenotypes. Overall, our data indicate that blocking hepatocyte division induces biological processes driving the onset of the disease phenotype. It suggests that the decrease in hepatocyte division observed in liver disease may not only be a consequence of fibrosis and inflammation, but also a pathological cue. “Pathological” polyploidy is a hallmark of liver diseases like NAFLD and NASH. Since loss of Cdk1 induces polyploidy, we used a mouse model with a hepatocyte-specific deletion of Cdk1 or Ccna2 to study the immediate effects on liver physiology. To our surprise, impaired hepatocyte proliferation results in the development of inflammation and fibrosis in young animals despite the lack of any treatment to promote liver damage. Furthermore, we show that this could be caused by polyploidy, as concurrent loss of Cdk2 reverses polyploidy and the inflammatory phenotype. Thus, we provide evidence that the loss of hepatocyte proliferation in liver disease is not only an outcome but could also be an etiology of liver pathology.

1 January 2014
Verified
Book Chapter
Closed access
JOJin Rong Ow
Jin Rong Ow
YTYong Hua Tan
Yong Hua Tan
YJYu Jin
Yu Jin
ABAvinash G. Bahirvani
Avinash G. Bahirvani
RTReshma Taneja
Reshma Taneja